Clinical Trial Update: A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ocrelizumab in participants with Progressive Multiple Sclerosis is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Progressive Multiple Sclerosis (PMS) | Phase 3 | Status: ACTIVE_NOT_RECRUITING